Sean Pinney to Exercise Tolerance
This is a "connection" page, showing publications Sean Pinney has written about Exercise Tolerance.
Connection Strength
0.042
-
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity? Cardiovasc Drugs Ther. 2019 02; 33(1):87-95.
Score: 0.042